Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules

Details for Australian Patent Application No. 2002305716 (hide)

International Classifications

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 60/293,402 23.05.01 US

8 May 2003 Application Open to Public Inspection

Published as AU-B-2002305716

25 October 2007 Application Accepted

Published as AU-B-2002305716

29 November 2007 Corrigenda

Applications Accepted - Name Index Under tha name Bristol-Myers Squibb Company, Application NO. 2002305716, under INID (72), correct the co-inventor name to read Pearson, Thomas C.

14 February 2008 Application for Amendment

The nature of the amendment is: Amend the names of the co-inventors from Larsen, Christian P.; Adams, Andrew B. and Pearson, Thomas C. to Peach, Robert J.; Adams, Andrew B.; Larsen, Christian P.; Naemura, Joseph R.; Bajorath, Jurgen; Linsley, Peter S. and Pearson, Thomas C.. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000

5 June 2008 Amendment Made

The nature of the amendment is: Amend the name of the inventors to read: Adams, Andrew B.; Larsen, Christian P.; Bajorath, Jurgen; Pearson, Thomas C.; Peach, Robert J.; Linsley, Peter S. and Naemura, Joseph R.

12 June 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.